Design, Structure−Activity Relationships and in Vivo Characterization of 4-Amino-3-benzimidazol-2-ylhydroquinolin-2-ones: A Novel Class of Receptor Tyrosine Kinase Inhibitors-Reference-Cited by-同舟云学术

Design, Structure−Activity Relationships and in Vivo Characterization of 4-Amino-3-benzimidazol-2-ylhydroquinolin-2-ones: A Novel Class of Receptor Tyrosine Kinase Inhibitors

Published:2008-12-29 Issue:2 Volume:52 Page:278-292
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Renhowe Paul A.¹,Pecchi Sabina¹,Shafer Cynthia M.¹,Machajewski Timothy D.¹,Jazan Elisa M.¹,Taylor Clarke¹,Antonios-McCrea William¹,McBride Christopher M.¹,Frazier Kelly¹,Wiesmann Marion¹,Lapointe Gena R.¹,Feucht Paul H.¹,Warne Robert L.¹,Heise Carla C.¹,Menezes Daniel¹,Aardalen Kimberly¹,Ye Helen¹,He Molly¹,Le Vincent¹,Vora Jayesh¹,Jansen Johanna M.¹,Wernette-Hammond Mary Ellen¹,Harris Alex L.¹

Affiliation:

1. Novartis Institutes for Biomedical Research, 4560 Horton Street, Emeryville, California 94608-2419

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm800790t

Reference38 articles.

1. ISOLATION OF A TUMOR FACTOR RESPONSIBLE FOR ANGIOGENESIS

2. Mechanisms of angiogenesis and arteriogenesis

3. Expression offgf andfgf receptor genes in human breast cancer